Stay updated on Comparing GA-GCB ERT With Imiglucerase in GD Clinical Trial
Sign up to get notified when there's something new on the Comparing GA-GCB ERT With Imiglucerase in GD Clinical Trial page.

Latest updates to the Comparing GA-GCB ERT With Imiglucerase in GD Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedThe page shows a new revision tag, v3.3.2, replacing v3.3.1. No study data or eligibility information is affected.SummaryDifference0.1%

- Check20 days agoChange DetectedPublications are now described as automatically filled from PubMed and possibly not related to the study, with the revision updated to v3.3.1. The deletion text was revised to reflect automatic PubMed sourcing and generation by the NCT number, with the revision noted as v3.2.0.SummaryDifference0.1%

- Check28 days agoChange DetectedRemoved the funding-status banner that warned data may be out of date and pointed users to NIH/OPM status pages.SummaryDifference0.4%

- Check42 days agoChange DetectedThe updates show minor formatting and layout adjustments; core study information such as GA-GCB vs imiglucerase, eligibility criteria, and outcome measures appears unchanged.SummaryDifference0.3%

- Check71 days agoChange DetectedUpgrade to v3.2.0 with a government operating-status notice and links to status pages; removes the previous v3.1.0 reference.SummaryDifference4%

- Check78 days agoChange DetectedVersion updated from v3.0.2 to v3.1.0; no substantive content changes detected.SummaryDifference0.1%

Stay in the know with updates to Comparing GA-GCB ERT With Imiglucerase in GD Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Comparing GA-GCB ERT With Imiglucerase in GD Clinical Trial page.